Navigation Links
Large Vein Occlusive Disease: Diagnosis and Treatment Options to be Presented at the 40th Annual VEITHsymposium in New York
Date:11/20/2013

NEW YORK, Nov. 20, 2013 /PRNewswire-iReach/ -- Large vein occlusive disease is on the rise, especially in diabetic patients.  Management of deep vein thrombosis (DVT) of the upper extremity due to thoracic outlet syndrome compressing the subclavian vein and of the lower extremity due to iliac vein stenosis remains controversial.  Media is invited to attend any and all presentations relative to large vein occlusive disease presented at the 40th Annual VEITHsymposium in New York. The session will commence on Thursday, November 21st, 1:00 P.M. to 5:00 P.M. located in Americas Hall I, 3rd Floor of the New York Hilton-Midtown (NY, NY). Kenneth Ouriel, MD, MBA, FACS, FACC will moderate the session.

    Dr. Ouriel said, "This session will be particularly interesting to the media.  We will discuss state-of-the-art diagnostic and treatment modalities for large vein occlusion in the upper and lower extremities.  Therapy for axillo/subclavian and lower extremity venous stenotic and occlusive disease continues to evolve, with accumulating data on pharmacologic, mechanical, and open surgical modalities. There is much to be learned."  Media will have an opporunity to interview presenters in the VEITHsymposium press office. 

     The recent advent of stents engineered specifically for the venous anatomy and physiology provides a timely setting to discuss the indications and early outcome of endovascular therapy for venous occlusion.  Lastly, clinicians who are highly skilled in these demanding procedures will present the indications and operative techniques for major open surgical reconstruction of the vena cava and other large veins. 

     Ouriel concluded, "In short, accumulating data on large vessel venous occlusion affords opportunities for the patient and the vascular practitioner alike.  Newly gained knowledge of the disease and the results of treatment can be applied to a larger proportion of the underserved population with venous disease; at the same time expanding the armamentarium of effective interventions available to the practicing clinician."  

     Experts will address the unmet needs and opportunities for the future, other commonly encountered venous occlusive problems and their treatment, treatment of lower extremityDVT, balloons, stents, thrombolysis, ultrasound thrombolysis, mechanical thrombectomy, and inferior vena caval issues (including endovascular and open surgical management). 

     About VEITHsymposium: Now in its fourth decade, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features over 750 rapid-fire presentations from world-renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. To register to attend the VEITHsymposium, please visit www.VEITHpress.org or contact Pauline T. Mayer at 631.979.3780 or email.

Media Contact: Pauline Mayer, PTM Healthcare Marketing, Inc., 631-979-3780, ptm@ptmhcm.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE VEITHsymposium
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ViGene Biosciences Introduces Worlds Largest Collection of Pre-Made Human Full-Length cDNA ORF and miRNA Adenoviruses
2. Does Your Business Have the Tools to Compete in the Worlds Largest Diagnostics Markets?
3. Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013
4. DNA Diagnostics Center (DDC), One of the Worlds Largest DNA Testing Companies, Increases the Identification Power of its DNA Tests by More Than 500%
5. B. Braun Receives FDA Approval For New Large-Volume Irrigation Containers
6. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
7. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
8. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
9. Large-Scale Global Registry to Examine Treatment Patterns and Disease Burden Among Patients with Venous Thromboembolism (VTE)
10. SERVE-HF; the Worlds Largest Study of Sleep-Disordered Breathing in Heart Failure Completes Recruitment
11. Large-Scale Kaiser Permanente Program Linked to Improved Blood Pressure Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Research and Markets has announced the addition of the "Active ... (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), Therapy (Diabetes, Oncology, ... offering. ... global active pharmaceutical ingredients market is expected to reach USD 213.97 ... a CAGR of 6.3% from 2016 to 2021. ...
(Date:1/17/2017)... 17, 2017 Immune Pharmaceuticals (NASDAQ: ... today that it will hold a Satellite Symposium on February ... (ISAL) XVI in Munich, Germany . ... Efficacy of Immunotherapy for the maintenance of remission in ... 20 th , 2017 from 12:45 – 13:45 CET ...
(Date:1/17/2017)... Interpace Diagnostics Group, Inc., (NASDAQ: IDXG ... tests and pathology services for evaluating risks of cancer, ... January 13, 2017 from the NASDAQ Listing Qualifications notifying ... requirement of the NASDAQ Stock Market to maintain a ... The letter noted that for the last 10 ...
Breaking Medicine Technology:
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... ... County, as well as Palm Desert, is opening a new office in San ... deep transcranial magnetic stimulation (dTMS) in Southern California, successfully treating individuals struggling with ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New York’s ... care practitioners on the latest breakthroughs in the prevention, diagnosis and treatment of ... according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD ...
(Date:1/17/2017)... ... 17, 2017 , ... Wettstein Agencies, a Denver area firm ... throughout central Colorado, is joining local nonprofit Aurora Warms The Night to provide ... organization is committed to breaking the cycle of homelessness and poverty affecting a ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians Education Review®, LCC (PER®) ... speaker for the 34th Annual Miami Breast Cancer Conference®, on March 9-12, 2017 ... Phil Talamo, said, “We are delighted to have Sandra Lee join us as ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, FloSports , a global leader in ... agreement as part of a long-term extension of their media partnership. The partnership, which ... some of the sport’s premier events exclusively on FloWrestling.com as well as usage of ...
Breaking Medicine News(10 mins):